Clinical trial

Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir…

NCT00344123 · Johns Hopkins University, Other · Completed

Key facts

NCT number NCT00344123
Title Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects
Official title Pharmacokinetic Evaluation of Single-dose Rosuvastatin 10 mg When Co-administered With Steady-state Tipranavir 500 mg/Ritonavir 200 mg TPV/r) B.I.D. in Healthy Adult Volunteers
Lead sponsor Johns Hopkins University, Other
Collaborators Boehringer Ingelheim Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Tipranavir/Ritonavir, Rosuvastatin
Enrollment 29
Start date Feb 1, 2007
Primary completion May 1, 2008
Completion May 1, 2008
First posted Jun 26, 2006
Last update posted Feb 4, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies